insights_auto
Why is RHHVF down 3.84%?
Dive Deeperchevron_right
RHHVF:OTCMKTS
Roche Holding AG Genussscheine
$414.98
arrow_downward
-3.84%(-16.58) 1D
Sep 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHVF...
Open
$418.59
High
$442.60
Low
$413.00
Mkt. cap
339.14B
Avg. vol.
5.75K
Volume
222.00
52-wk high
$490.33
52-wk low
$318.81
Beta
0.54
Shares outstanding
702.56M
No. of employees
113K
Open
$418.59
High
$442.60
Low
$413.00
Mkt. cap
339.14B
Avg. vol.
5.75K
Volume
222.00
52-wk high
$490.33
52-wk low
$318.81
Beta
0.54
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
AD HOC NEWS
·
12 hours ago
Roche Holding stock: FDA accepts fenebrutinib application for priority review
AD HOC NEWS
·
18 hours ago
Roche Holding stock reports 6.00 percent first half sales growth
Stock Titan
·
23 hours ago
One trial found Roche's experimental MS treatment cut relapse rates by 58.5% versus standard care.
Euronext Markets: Real-time Stock Market Data | live
·
2 days ago
Roche outlines plans to move towards autonomous AI labs
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com